Highest-materiality recent filing
Enovix appoints former Apple operations leader Michael Vyvoda as COO effective July 29, 2026
Dr. Michael Vyvoda, former Apple Director of Product Operations for AirPods, named COO effective July 29, 2026.
All 8 director nominees re-elected: each received >73M votes for; broker non-votes ~63.7M each.
Revenue $7.6M, up 49% YoY, above guidance high end; GAAP net loss $0.18/sh, non-GAAP loss $0.14/sh.
Steve Bakos appointed SVP Worldwide Sales, effective May 5, 2026; reports to Chief Business Officer Samira Naraghi.
Enovix Q4 revenue $11.3M, FY revenue $31.8M (+38% YoY); board authorizes $75M buyback
Q4 2025 revenue $11.3M (record, up 16% YoY from $9.7M); FY2025 revenue $31.8M (up 38% from $23.1M).
Enovix COO retiring Feb 17; preliminary 2025 revenue growth ~38%
COO Ajay Marathe to retire effective Feb 17, 2026; no disagreement cited.
Enovix Q3 revenue $8M (+85% YoY), beats guidance; raises Q4 revenue view to $9.5-10.5M
Revenue $8.0M (+85% YoY), above prior guidance $7.5-8.5M; Q4 revenue guidance raised to $9.5-10.5M.
Enovix closes $360M convertible note offering at 4.75% due 2030; conversion price $11.21
$360M aggregate principal of 4.75% convertible senior notes due Sept 15, 2030; conversion price $11.21 (22.5% premium over last sale).
Enovix completes warrant dividend financing; no financial details disclosed
Enovix updated its investor presentation following the conclusion of its warrant dividend financing.
Enovix completes warrant dividend program, raises $232.1M gross proceeds
Approximately 26.5M warrants exercised, generating $232.1M gross proceeds for Enovix.
Enovix warrants early expiration triggered; final exercise Aug 29; $107.5M proceeds
VWAP exceeded $10.50 triggering early expiration; alternate expiration date set for Aug 29, 2025.
Enovix warrants expire Aug 29; price condition met, 12.6M exercised for $110M
Alternate price condition satisfied; warrants expire Aug 29, 2025; trading ends at 4pm ET, exercise deadline 5pm ET.
Enovix reappoints veteran semiconductor leader Dan McCranie to Board
Appointed J. Daniel 'Dan' McCranie to Board effective Aug 12, 2025; Board expands to 8 directors, 6 independent.
Enovix Q2 revenue $7.5M (+98% YoY); AI-1 platform launched; non-GAAP EPS loss $0.13 beats guidance
Revenue of $7.5M beat guidance of $4.5-6.5M; third consecutive quarter of positive gross margin (non-GAAP 31%).
Enovix stock price triggers potential early warrant expiration as early as Aug 19
Common stock closed at $15.06, above $10.50 threshold for five trading days.
Record date July 17, 2025; distribution date July 21, 2025; one warrant per seven shares held, rounded down.
Record date July 17, 2025; distribution date on/about July 21, 2025; one warrant per 7 shares held.
Enovix Q2 rev $7.5M (+98% YoY), beats guidance; GAAP gross profit positive 3rd straight quarter
Revenue $7.5M, up 98% YoY, exceeded guidance of $4.5M-$6.5M.
Enovix declares warrant dividend: 1 warrant per 7 shares, $8.75 exercise, up to $253.8M proceeds
Each common stockholder receives 1 warrant for every 7 shares held as of July 17, 2025 record date.
Enovix authorizes $60M share repurchase program through Dec 2026
Board authorized repurchase of up to $60M of common stock; effective June 30, 2025, expires Dec 31, 2026.
Enovix shareholders elect all seven directors, approve say-on-pay and auditor
All seven director nominees elected with 64-71M votes for each; broker non-votes were 57.3M.
Enovix Q1 revenue $5.1M, beats guidance midpoint; net loss $0.12/share; guides Q2 revenue $4.5-6.5M
Q1 revenue $5.1M (near high end of guidance); GAAP net loss $23.5M ($0.12 loss per share).
Enovix appoints Ryan Benton as CFO effective April 14, 2025
Ryan Benton was appointed CFO effective April 14, 2025; over 30 years of financial leadership experience.
Enovix acquires SolarEdge battery cell manufacturing facility in South Korea
Acquires ~330,000 sq ft facility directly adjacent to existing Nonsan City plant; deal expected to close April 2025.
Enovix reports record Q4 revenue $9.7M; first positive gross margin; smartphone samples shipped
Q4 revenue $9.7M (record), full-year $23.1M, up 202% YoY; first positive GAAP gross margin of $1.1M (11% of sales).
Enovix appoints Kristina Truong as first SVP & Chief Accounting Officer
Kristina Truong named SVP and Chief Accounting Officer, effective Dec 30, 2024.
Enovix CFO Farhan Ahmad departs; company initiates search for replacement
CFO Farhan Ahmad left effective immediately, not due to disagreement with operations or policies.
Enovix prices $100M public offering of 10.4M shares at $9.22/share
Gross proceeds of $100M from 10,416,667 shares at $9.22 per share; underwriter option for 1,562,500 additional shares.
Enovix Q3 revenue $4.3M, GAAP net loss $22.5M; opens Fab2, secures second smartphone OEM partnership
Revenue $4.3M (above guidance midpoint), up from $3.8M Q2; GAAP net loss $22.5M improved from $115.9M Q2.
Enovix Q2 revenue $3.8M, beats guidance; Malaysia Agility Line producing first batteries
GAAP net loss $115.9M vs $46.4M in Q1; includes $38.1M restructuring and $33.7M warrant expense.
Enovix stockholders elect all seven directors, approve say-on-pay, ratify Deloitte auditor
All 7 director nominees elected: Rodgers, Atkins, Ebrahimi, Gutmann, Malchow, Reichow, Talluri.
Enovix Q1 revenue $5.3M beats guidance; non-GAAP gross profit positive for first time
Revenue of $5.3M (up from $21K YoY) exceeded guidance of $3.5-4.5M; non-GAAP gross profit turned positive.
Enovix Q4 revenue $7.4M, record top line; Fab2 on track for April samples
Q4 revenue $7.4M vs $0.2M Q3 and $1.1M YoY; driven by Routejade acquisition and Army shipments.
Enovix Q3 revenue $0.2M; cash $371.3M; narrows FY2023 cash use guidance to $110M
Q3 revenue $0.2M from U.S. Army cells; GAAP cost of revenue $16.8M; GAAP op. expenses $33.8M.
Workforce reduction of ~185 personnel (including over 125 contractors) with restructuring charge of ~$2.5M.
Enovix board member Emmanuel Hernandez to retire; Gutmann becomes Audit Chair
Emmanuel T. Hernandez retires from Enovix board effective Sept. 30, 2023; not due to any disagreement.
Enovix acquires Routejade for ~$16.5M cash + 6.2M shares; accretive, vertical integration
Total consideration of ~6.2M Enovix shares and ~$16.5M cash for 100% of Routejade.
Enovix enters deposit agreement to collateralize $70M loan for Malaysia manufacturing
Enovix will deposit cash into a restricted OCBC account equal to OSSB drawdowns under a $70M loan for manufacturing.
Enovix signs YBS manufacturing deal for $70M funding; Q2 rev $42K, units beat plan
YBS agreement: $100M equipment investment, Enovix 30%/YBS 70% funded by OCBC; 10-year term.
Enovix names Farhan Ahmad as CFO; outgoing CFO Steffen Pietzke to consult after July 9
CFO Steffen Pietzke resigns effective July 9, 2023; will provide consulting for up to 6 months in exchange for $400K RSU grant.
Enovix appoints Joseph Malchow and Bernard Gutmann to board; expands to 8 directors
Malchow (HNVR founding partner, ex-Enphase director) and Gutmann (former ON Semi CFO) join board effective June 22, 2023.
All six director nominees elected with majority support; broker non-votes ~40.3M shares.
Enovix Q1 production beats plan at 12,500 units; GAAP net loss $73.6M, non-GAAP loss $0.20/share
Produced 12,500 full-qual units, beating plan of 9,000; 2.8x over Q4 2022's 4,442 units.
Enovix closes $172.5M convertible note offering at 3.00% due 2028; net proceeds ~$165.7M
Issued $172.5M of 3.00% Convertible Senior Notes due 2028; includes $22.5M option exercise and $10M affiliate placement.
Enovix Q1 Fab-1 output of 12,500 cells beats 9,000 forecast; seeks $70M non-dilutive financing
Produced 12,500 battery cells in Q1 ending Apr 2, 2023, exceeding forecast of 9,000 cells.
Enovix Q4 2022 revenue $1.1M, net loss $11.2M; guides 180K cells in 2023
Q4 2022 revenue $1.1M (service); GAAP net loss $11.2M ($0.07/share); Non-GAAP net loss $29.2M ($0.19/share).
Enovix appoints Gregory Reichow as Compensation Committee chair, adds Audit Committee role
Gregory Reichow appointed chair of Compensation Committee effective Jan 24, 2023.
Enovix CTO to retire, CCO resigns; Ralph Schmitt appointed new CCO
CTO Ashok Lahiri retiring effective Feb 1, 2023; remains as advisory board lead.
Director John D. McCranie resigns from Enovix board effective Jan 20
John D. McCranie resigned from the Board effective January 20, 2023.
Enovix CEO Harrold Rust retires; Raj Talluri named successor; separation details disclosed
Harrold Rust resigns as CEO, President, and Board member effective Jan 18, 2023; remains employee through Feb 1.
On July 9, 2026, Enovix Corporation (the “Company”) announced that it is appointing Dr. Michael Vyvoda as Chief Operating Officer of the Company, effective July 29, 2026 (the “Effective Date”).
On April 17, 2025, Enovix Corporation (the “Company”) announced that Ryan Benton had been appointed as Chief Financial Officer (“CFO”) of the Company.
On December 30, 2024, Enovix Corporation (the “Company”) appointed Kristina Truong as Senior Vice President and Chief Accounting Officer.
Emmanuel T. Hernandez will retire from the Board effective September 30, 2023.
Steffen Pietzke will resign as Chief Financial Officer of Enovix Corporation (the “Company”), effective as of July 9, 2023.
Mr. Pietzke’s successor, Farhan Ahmad, had been appointed Chief Financial Officer of the Company.
On June 22, 2023, the Board of Directors (the “Board”) of Enovix Corporation (the “Company”) approved an increase in the total authorized number of members of the Board to eight directors and appointed Joseph Malchow and Bernard Gutmann (together, the “New Directors”) to fill the newly created vacancies as directors whose terms will expire at the Company’s 2024 annual meeting of stockholders.
On June 22, 2023, the Board of Directors (the “Board”) of Enovix Corporation (the “Company”) approved an increase in the total authorized number of members of the Board to eight directors and appointed Joseph Malchow and Bernard Gutmann (together, the “New Directors”) to fill the newly created vacancies as directors whose terms will expire at the Company’s 2024 annual meeting of stockholders.
Cameron Dales determined that he will resign as the Company’s General Manager and Chief Commercial Officer, effective as of February 1, 2023
Ashok Lahiri determined that he will retire as Chief Technology Officer of Enovix Corporation (the “Company”), effective as of February 1, 2023
On January 17, 2023, John D. McCranie, a member of the Board of Directors (the “Board”) of Enovix Corporation (the “Company”), provided notice of his resignation as a member of the Board, effective as of January 20, 2023.
Mr. Rust determined that he would retire as President and Chief Executive Officer of the Company and as a member of the Board effective as of the date of Dr. Talluri’s appointment to each such position.
Max materiality 0.80 · Median 0.65 · Most common event other_material